09/05/2024
4:02 PM | Fennec Pharmaceuticals (Subject)
Haigh Adrian (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/04/2024
5:33 PM | Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
5:48 PM | Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/27/2024
4:30 PM | Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
| Form 4/A | |
08/26/2024
4:51 PM | Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
5:59 PM | Fennec Pharmaceuticals (Issuer)
Hackman Jeffrey S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
6:00 PM | Fennec Pharmaceuticals (Issuer)
RALLIS CHRIS A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
08/19/2024
6:00 PM | Brughera Marco Maria (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
6:01 PM | Cook Jodi A (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
6:02 PM | Fennec Pharmaceuticals (Issuer)
Islam Khalid (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
5:56 PM | Fennec Pharmaceuticals (Issuer)
Hackman Jeffrey S. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/13/2024
4:10 PM | Fennec Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/01/2024
3:30 PM | Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2024
3:21 PM | Fennec Pharmaceuticals (Subject)
Raykov Rosty (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/02/2024
4:55 PM | Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
4:42 PM | Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
3:43 PM | DG Capital Management, LLC (Filed by)
Fennec Pharmaceuticals (Subject)
| Form SC 13G | |
06/03/2024
5:21 PM | Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
4:12 PM | Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
4:05 PM | Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
4:05 PM | Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
4:05 PM | Fennec Pharmaceuticals (Issuer)
Haigh Adrian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2024
4:24 PM | Fennec Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/13/2024
3:42 PM | Fennec Pharmaceuticals (Filer)
| Form DEF 14A | |
05/02/2024
3:59 PM | Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/26/2024
3:15 PM | Fennec Pharmaceuticals (Issuer)
Haigh Adrian (Reporting)
| Form 4/A | |
04/22/2024
6:34 PM | Fennec Pharmaceuticals (Issuer)
Haigh Adrian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/22/2024
3:21 PM | Fennec Pharmaceuticals (Subject)
Haigh Adrian (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/18/2024
8:43 PM | Fennec Pharmaceuticals (Issuer)
Haigh Adrian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/18/2024
3:24 PM | Fennec Pharmaceuticals (Subject)
Haigh Adrian (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/17/2024
3:23 PM | Fennec Pharmaceuticals (Subject)
Haigh Adrian (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/16/2024
5:00 PM | Fennec Pharmaceuticals (Issuer)
Haigh Adrian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/16/2024
3:15 PM | Fennec Pharmaceuticals (Subject)
Haigh Adrian (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/15/2024
5:15 PM | Fennec Pharmaceuticals (Issuer)
RALLIS CHRIS A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/15/2024
3:28 PM | Fennec Pharmaceuticals (Subject)
Haigh Adrian (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/05/2024
3:19 PM | Fennec Pharmaceuticals (Subject)
Raykov Rosty (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/04/2024
3:46 PM | Fennec Pharmaceuticals (Subject)
Raykov Rosty (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/03/2024
4:37 PM | Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
3:55 PM | Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
4:00 PM | Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/29/2024
3:14 PM | Fennec Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
The solution to fast food’s wage hike crisis (Ad) Shake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase, according to the NY Post.
With a sky-high 150% turnover rate, the fast food industry is already grappling with labor issues before taking into account these wage hikes. The industry will need a projected 1 million new workers every year through 2032. Learn more about this much-needed advancement and investment opportunity here. |
03/27/2024
3:22 PM | Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
3:24 PM | Fennec Pharmaceuticals (Issuer)
RALLIS CHRIS A (Reporting)
RALLIS CHRIS A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2024
3:43 PM | Andrade Robert (Reporting)
Fennec Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/25/2024
6:31 PM | Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2024
3:05 PM | Fennec Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/15/2024
2:53 PM | Fennec Pharmaceuticals (Filer)
| Form 424B7 | |
01/05/2024
4:24 PM | Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
3:45 PM | Andrade Robert (Reporting)
Fennec Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/04/2024
3:42 PM | Andrade Robert (Reporting)
Fennec Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/29/2023
3:30 PM | Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2023
2:51 PM | Fennec Pharmaceuticals (Subject)
Raykov Rosty (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/17/2023
11:15 PM | Fennec Pharmaceuticals (Filer)
| Form EFFECT | |
12/05/2023
7:51 PM | Fennec Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/20/2023
8:20 PM | Fennec Pharmaceuticals (Issuer)
RALLIS CHRIS A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/09/2023
3:52 PM | Fennec Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/09/2023
3:56 PM | Fennec Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
11/08/2023
5:19 PM | Fennec Pharmaceuticals (Subject)
Raykov Rosty (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/06/2023
6:38 PM | Fennec Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/03/2023
4:19 PM | Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Free FENC Stock Alerts